Who
Brett I. W. Zbar
Director
Company insider
Files Form 4 as: Director, Centessa Pharmaceuticals; Director, Minrad International.
In numbers
- Trades disclosed
- 18
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 13 Mar 2007
- Last trade
- 24 Jun 2026
- Last filed
- 24 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —64,570 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —48,000 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —48,000 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —64,570 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —48,000 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —48,000 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —48,000 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —40,000 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —48,000 | filing |
| 24 Jun 2026filed 24 Jun 2026 | Centessa Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code D | —40,000 | filing |
| 20 Jun 2025filed 24 Jun 2025 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 25 Jun 2024filed 27 Jun 2024 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —48,000 at $0.00 | filing |
| 22 Jun 2023filed 23 Jun 2023 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —48,000 at $0.00 | filing |
| 30 Jun 2022filed 5 Jul 2022 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —48,000 at $0.00 | filing |
| 1 Jul 2021filed 6 Jul 2021 | Centessa Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —64,570 at $0.00 | filing |
| 27 Feb 2009filed 3 Mar 2009 | Minrad Internationaloption or derivative | SEC FORM 4 Code D | —25,000 | filing |
| 27 Feb 2009filed 3 Mar 2009 | Minrad Internationaloption or derivative | SEC FORM 4 Code D | —25,000 | filing |
| 13 Mar 2007filed 30 Mar 2007 | Minrad Internationaloption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.